Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. | 24,150 | reported | 11 Jun 2025 | tx 9+197,790 |
| Kymera Therapeutics, Inc. | 16,000 | reported | 25 Jun 2025 | tx 6+116,190 |
| Rain Therapeutics Inc. | 0 | reported | 26 Jan 2024 | tx 4+55,000−55,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Jun 2025 | GRANT_AWARD | Kymera Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 24,150 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | Kymera Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 14 Jun 2024 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 23,000 | 0.00 USD | deriv |
| 26 Jan 2024 | OTHER | Rain Therapeutics Inc. | 20,000 | — | deriv |
| 26 Jan 2024 | OTHER | Rain Therapeutics Inc. | 35,000 | — | deriv |
| 09 Aug 2023 | GRANT_AWARD | Rain Therapeutics Inc. | 35,000 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Kymera Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Rain Therapeutics Inc. | 20,000 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Kymera Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Kymera Therapeutics, Inc. | 20,063 | 0.00 USD | deriv |
| 09 Jun 2021 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 18 Nov 2020 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 18 Nov 2020 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 18 Nov 2020 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 20 Aug 2020 | GRANT_AWARD | Kymera Therapeutics, Inc. | 40,127 | 0.00 USD | deriv |